Freimann Professor of Physics
University of Notre Dame
Email: Ani Aprahamian
Phone: 574-631- 8120
Office: 225 Nieuwland Science Center (mailing)
Isotopes for cancer therapy and immuno-diagnosis
Ani Aprahamian is co-chair of a standing committee of the Nuclear Science Advisory Committee to study the present and potential research use of radioactive isotopes and to develop a strategy for production of the isotopes, which among other things are used to treat cancer. The committee’s recommendation will coordinate implementation of the National Isotope Production and Applications Program over the next decade. Don Geesaman of Argonne National Laboratory is co-chair of the study.
Small amounts of radioactive isotopes have become an important element of diagnosing and treating many types of cancer, heart disease, and other abnormalities in the body, but the failure of a European reactor and the shutdown of a Canadian reactor in late 2007 and early 2008 led to a global shortage, revealing the need for a U.S. strategic plan for production and development.
The U.S. Department of Energy’s Nuclear Energy Program has produced limited quantities of isotopes, and the Isotope Production Program is scheduled to move from the Office of Nuclear Energy to the Office of Science’s Nuclear Physics.